GlassScriptPhysician profile
Ajaratu Keshinro
NPI 1083061949
$2,272.97
in general payments reported to CMS, 2019-2025
10 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $441 · 2023: $497 · 2024: $445 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,831.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $981.84 | 2023-2025 | Interstim, Eea, Infinity Occipitocervical Upper Thoracic System |
| Allergan, INC. | $441.36 | 2022 | |
| Intuitive Surgical, INC. | $228.65 | 2024 | |
| Ethicon US, LLC | $187.66 | 2024-2025 | Echelon Flex, Echelon; Endopath |
| Innovation Technologies INC | $165.49 | 2025 | Irrisept |
| Davol INC. | $150.73 | 2023 | Phasix Mesh |
| Baxter Healthcare | $47.62 | 2023 | Hillrom - Fcs 700 Boom |
| Axonics, INC. | $32.57 | 2024 | Axonics |
| Lilly USA, LLC | $19.38 | 2024 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $17.67 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajaratu Keshinro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.